Patent · US Active

Compounds for treatment of cell proliferative diseases

US7745468B2 · kind B2 · utility

6Cited by
15References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 13, 2004
Grant dateJun 29, 2010
Priority date
Expiry dateMay 25, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D213/61
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as kinase inhibitors, cause the downregulation of c-myc, and inhibit the growth and survival of cancerous cell lines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.